ABOUT 2nd_OCIF
> AGENDA​
> REGISTRATION
​> ATTENDEES​
​> PRESENTERS​
​> SPONSORS​
> SUPPORTERS
​> NETWORKING
> VENUE
> ACCOMMODATION

> ABOUT LAST BOIF

supporters:

​Biotechgate

Biotechgate is the global Business Development Database for the Biotech, Pharma and Medtech industries.

Over 900,000 clinical trials
60,000 company database
Over 40,000 Biotech, Pharma and Medtech assets available for licensing
Over 350,000 management contact details
The latest M&A Deals
Product pipelines
In depth market research reports
​Dedicated investor database

www.biotechgate.com

FreeMind Group

FreeMind is a consulting group whose goal is to assist in maximizing potential to receive funding from non-dilutive sources. Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. FreeMind's proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date.

Our expertise in applying for grants and contracts extends throughout every government mechanism open to funding the life sciences including all NIH institutes, DoD, NSF, FDA, CDC, BARDA, etc., as well as private foundations.

FreeMind's knowledgeable and experienced team of Client Strategists and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award.  Our team of experts will assist in making non-dilutive funding a key tool in a long-term financial strategy.

www.freemindgroup.com

MEDiSTRAVA

MEDiSTRAVA Consulting is a new strategic communications and healthcare advisory group created to fast-track our biotech and pharma clients to success. We channel global expertise across corporate communications, investor relations, medical and regulatory affairs, HEOR and market access to enable clients to achieve their full potential.

www.medistrava.com

MedNous

MedNous is a print publication and a website for everyone involved in medical research in Europe. The name is derived from the Greek word for knowledge – nous – and the English word, medical.

The print publication analyses complex issues that life science professionals need to understand in order to bring their research into commercial development. These issues relate to regulatory affairs, patent law, government research policy and funding. The print publication appears 10 times per year and includes news, company interviews and commentary by corporate executives and other practicioners in this field.
​
www.mednous.com

​Swiss Biotech Association

Swiss Biotech unites the four leading biotech regions of Switzerland (BioAlps, BaselArea, Biopolo Ticino and Greater Zurich Area). The regions have early on combined efforts with the SWX Swiss Exchange which holds a leading position in terms of life-science listings and services.

The National Industry Association named Swiss Biotech Association Represents more than 150 companies to date and acts as the operational arm for the marketing alliance. Swiss Biotech raises Switzerland’s profile as an economic center in Europe and profiles the biotech industry with its key research institutions and companies.Swiss Biotechs’ mission is to spread the message of Switzerland as one of the top biotech locations in the world. This will be achieved by presenting a comprehensive picture of the drivers of biotechnology including research, education, economics, finance and industry. The bases for success in biotechnology are the critical mass of research institutes and accelerated technology transfer. The early integration of industry and well-trained workforce is another critical success factor for rapid economic growth. More than 40 technology parks throughout the country support the increasingly important and successful TechTransfer process.

www.swissbiotech.org

Tiberend Strategic Advisors,  Inc.

Tiberend Strategic Advisors, Inc. is a corporate communications firm providing media strategy and execution for life science companies – biotech (therapeutics), medical devices and diagnostics. We work with both public and private emerging growth companies:

1. To enhance valuation 
2. To build visibility for partnerships and strategic alliances

www.tiberend.com